Equipoise, drug development, and biliary cancer

Cancer. 2022 Mar 1;128(5):944-949. doi: 10.1002/cncr.34020. Epub 2021 Nov 24.

Authors

Tristan Y Lee¹, Susan E Bates¹, Ghassan K Abou-Alfa^{2

3}

Affiliations

¹ Vagelos College of Physicians and Surgeons, Columbia University, New York, New York.
² Memorial Sloan Kettering Cancer Center, New York, New York.
³ Weill Medical College, Cornell University, New York, New York.

PMID: 34817855
DOI: 10.1002/cncr.34020

No abstract available

Keywords: biliary cancer; cholangiocarcinoma; drug development; equipoise; precision medicine; targeted treatment.

MeSH terms

Bile Duct Neoplasms*
Biliary Tract Neoplasms* / drug therapy
Cholangiocarcinoma*
Drug Development
Humans
Therapeutic Equipoise